Home › Research › Caregiving
Contribution of Alzheimer disease to mortality in the United States
James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA.. Neurology, 2014-03-05
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective To assess the burden of mortality attributable to Alzheimer disease (AD) dementia in the United States. Methods Data came from 2,566 persons aged 65 years and older (mean 78.1 years) without dementia at baseline from 2 cohort studies of aging with identical annual diagnostic assessments of dementia. Because both studies require organ donation, ascertainment of mortality was complete and dates of death accurate. Mortality hazard ratios (HRs) after incident AD dementia were estimated per 10-year age strata from proportional hazards models. Population attributable risk percentage was derived to estimate excess mortality after a diagnosis of AD dementia. The number of excess deaths attributable to AD dementia in the United States was then estimated. Results Over an average of 8 years, 559 participants (21.8%) without dementia at baseline developed AD dementia and 1,090 (42.4%) died. Median time from AD dementia diagnosis to death was 3.8 years. The mortality HR for AD dementia was 4.30 (confidence interval = 3.33, 5.58) for ages 75-84 years and 2.77 (confidence interval = 2.37, 3.23) for ages 85 years and older (too few deaths after AD dementia in ages 65-74 were available to estimate HR). Population attributable risk percentage was 37.0% for ages 75-84 and 35.8% for ages 85 and older. An estimated 503,400 deaths in Americans aged 75 years and older were attributable to AD dementia in 2010. Conclusions A larger number of deaths are attributable to AD dementia in the United States each year than the number (<84,000 in 2010) reported on death certificates.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 2,566 participants. Following 2,566 older adults for about 8 years, this study estimated that 503,400 deaths among Americans aged 75 and older in 2010 were attributable to Alzheimer's dementia, far more than the fewer than 84,000 reported on death certificates that year. Reported effect size: 21.8%; 42.4%; 37.0%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
James, B. D., Leurgans, S. E., Hebert, L. E., Scherr, P. A., Yaffe, K., & Bennett, D. A. (2014). Contribution of Alzheimer disease to mortality in the United States. Neurology. https://doi.org/10.1212/wnl.0000000000000240
Vancouver
James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014. doi:10.1212/wnl.0000000000000240. PMID: 24598707.
BibTeX
@article{james2014-24598707,
author = {James, B. D. and Leurgans, S. E. and Hebert, L. E. and Scherr, P. A. and Yaffe, K. and Bennett, D. A.},
title = {{Contribution of Alzheimer disease to mortality in the United States}},
journal = {Neurology},
year = {2014},
doi = {10.1212/wnl.0000000000000240},
pmid = {24598707},
url = {https://doi.org/10.1212/wnl.0000000000000240}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Results Over an average of 8 years, 559 participants (21.8%) without dementia at baseline developed AD dementia and 1,090 (42.4%) died.
Why it matters
Following 2,566 older adults for about 8 years, this study estimated that 503,400 deaths among Americans aged 75 and older in 2010 were attributable to Alzheimer's dementia, far more than the fewer than 84,000 reported on death certificates that year. People who developed Alzheimer's dementia had a higher risk of death (hazard ratio 4.30 at ages 75–84, 2.77 at 85+), and the median time from diagnosis to death was 3.8 years. It measures the disease's mortality burden; it does not test any treatment or prevention.
New to this subject? Start with our plain-English guide: Caregiving →
Study details
- Study designcohort study
- Participants2,566
- Effect size21.8%; 42.4%; 37.0%
- Evidence strengthModerate
How this study scored 72/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Neurology) |
| Journal's citation record | 4 / 4 | Neurology: journal h-index 525 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2014 — within 20 year(s) of the newest study here |
| Sample size | 3 / 4 | 2,566 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 365 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 26.1 citations a year over 14 year(s) since 2014 |
| Impact for its field and year | 5 / 6 | Cited 25.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 3 / 6 | Cited by 24 other studies in this library |
| Still being cited | 3 / 4 | Cited 61 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author David Alan Bennett: h-index 197 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 24598707) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 72 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.
Later studies that cite this one
24 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Caregiving from nearby years
Also in Caregiving
69 studies in the library are filed under Caregiving with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Caregiving hub.